Skip to main content

Advertisement

Log in

Ambulatory Blood Pressure in Stroke and Cognitive Dysfunction

  • Blood Pressure Monitoring and Management (J Redon, Section Editor)
  • Published:
Current Hypertension Reports Aims and scope Submit manuscript

Abstract

We have reviewed the most relevant data regarding ABPM and brain damage, with specific reference to first and recurrent stroke, silent structural brain lesions such as lacunar infarcts and white matter lesions, and cognitive impairment. Only two large studies have evaluated the usefulness of ABPM in relation to antihypertensive treatment in primary stroke prevention. In the Syst-Eur trial, drug treatment reduced ABPM and office BP more than placebo in patients with sustained isolated systolic hypertension (ISH). In contrast, in those patients with white-coat hypertension (WCH) changes in ABPM between the treatment groups were not significantly different. Patients with WCH had a lower incidence of stroke (p < 0.05) during follow-up than patients with sustained ISH, suggesting that WCH is a benign condition. In the HYVET trial 50 % of the very elderly patients included with office systolic BP > 160 mmHg had WCH. However, a significant 30 % stroke reduction was observed in treated patients including those with WCH, indicating that WCH may not be a benign condition in the elderly. In the acute stroke setting, where treatment of hypertension is not routinely recommended due to the lack of evidence and the differing results of the very few available trials, ABPM data shows that sustained high BP during the first 24 h after acute stroke is related to the formation of cerebral edema and a poorer functional status. On the other hand, even when nondipping status was initially related to a poorer prognosis, data indicate that patients with very-large nocturnal dipping, the so-called “extreme dippers”, are those with the worse outcomes after stroke. The association between different ABPM parameters (circadian pattern, short-term variability) and poorer performance scores in cognitive function tests have been reported, especially in elderly hypertensives. Unfortunately most of these studies were cross-sectional and the associations do not establish causality.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

Papers of particular interest have been highlighted as: • Of importance

  1. James GD, Pickering TG, Yees LS, et al. The reproducibility of average ambulatory, home and clinic pressures. Hypertension. 1988;11:545–9.

    Article  PubMed  CAS  Google Scholar 

  2. Pickering TG. The clinical significance of diurnal blood pressure variations: dippers and nondippers. Circulation. 1990;81:700–2.

    Article  PubMed  CAS  Google Scholar 

  3. Pickering TG, Shimbo D, Haas D. Ambulatory blood-pressure monitoring. N Engl J Med. 2006;354:2368–74.

    Article  PubMed  CAS  Google Scholar 

  4. • Bliziotis IA, Destounis A, Stergiou GS. Home versus ambulatory and office blood pressure in predicting target organ damage in hypertension: a systematic review and meta-analysis. J Hypertens. 2012;30:1289–99. This is the recently and more completed review of the actual evidence about the role of out-office blood pressure values (home or ambulatory) in predicting target organ damage.

    Article  PubMed  CAS  Google Scholar 

  5. Staessen JA, Thijs L, Fagard R, et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. JAMA. 1999;282:539–46.

    Article  PubMed  CAS  Google Scholar 

  6. Dolan E, Stanton A, Thijs L, et al. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension. 2005;46:156–61.

    Article  PubMed  CAS  Google Scholar 

  7. Conen D, Bamberg F. Noninvasive 24-h ambulatory blood pressure and cardiovascular disease: a systematic review and meta-analysis. J Hypertens. 2008;26:1290–9.

    Article  PubMed  CAS  Google Scholar 

  8. Fagard RH, Celis H, Thijs L, et al. Daytime and nighttime blood pressure as predictors of death and cause-specific cardiovascular events in hypertension. Hypertension. 2008;51:55–61.

    Article  PubMed  CAS  Google Scholar 

  9. Fagard RH, Thijs L, Staessen JA, et al. Prognostic significance of ambulatory blood pressure in hypertensive patients with history of cardiovascular disease. Blood Press Monit. 2008;13:325–32.

    Article  PubMed  Google Scholar 

  10. Hansen TW, Li Y, Boggia J, et al. Predictive role of the nighttime blood pressure. Hypertension. 2011;57:3–10.

    Article  PubMed  CAS  Google Scholar 

  11. Kario K, Pickering TG, Matsuo T, et al. Stroke prognosis and abnormal nocturnal blood pressure falls in older hypertensives. Hypertension. 2001;38:852–7.

    Article  PubMed  CAS  Google Scholar 

  12. Ohkubo T, Hozawa A, Nagai K, et al. Prediction of stroke by ambulatory blood pressure monitoring versus screening blood pressure measurements in a general population: the Ohasama Study. J Hypertens. 2000;18:847–54.

    Article  PubMed  CAS  Google Scholar 

  13. Staessen JA, Gasowski J, Wang JG, et al. Risks of untreated and treated isolated systolichypertension in the elderly: meta-analysis of outcome trials. Lancet. 2000;355:865–72.

    Article  PubMed  CAS  Google Scholar 

  14. Inoue R, Ohkubo T, Kikuya M, et al. Risk in systolic and combined systolic and diastolic hypertension determined using ambulatory blood pressure the Ohasama Study. Am J Hypertens. 2007;20:1125–31.

    Article  PubMed  Google Scholar 

  15. Pickering T, Schwartz J, Verdecchia P, et al. Prediction of strokes versus cardiac events by ambulatory monitoring of blood pressure: results from an international database. Blood Press Monit. 2007;12:397–9.

    Article  PubMed  Google Scholar 

  16. Kobrin I, Oigman W, Kumar A, et al. Diurnal variation of blood pressure in elderly patients with essential hypertension. J Am Geriatr Soc. 1984;2:896–9.

    Google Scholar 

  17. Shimada K, Kawamoto A, Matsubayashi K, et al. Diurnal blood pressure variations and silent cerebrovascular damage in elderly patients with hypertension. J Hypertens. 1992;10:875–8.

    PubMed  CAS  Google Scholar 

  18. Verdecchia P, Porcellati C, Schillaci G, et al. Ambulatory blood pressure: an independent predictor of prognosis in essential hypertension. Hypertension. 1994;24:793–801.

    Article  PubMed  CAS  Google Scholar 

  19. Ohkubo T, Imai Y, Tsuji I, et al. Relation between nocturnal decline in blood pressure and mortality. Ohasama Study. Am J Hypertens. 1997;10:1201–7.

    Article  PubMed  CAS  Google Scholar 

  20. Verdecchia P, Schillaci G, Borgioni C, et al. Altered circadian blood profile and prognosis. Blood Press Monit. 1997;2:347–52.

    PubMed  Google Scholar 

  21. Kario K, Matsuo T, Kobayashi H, et al. Relation between nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensives: advanced silent cerebrovascular damage in extreme-dippers. Hypertension. 1996;27:130–5.

    Article  PubMed  CAS  Google Scholar 

  22. • Metoki H, Ohkubo T, Imai Y. Diurnal blood pressure variation and cardiovascular prognosis in a community-based study of Ohasama, Japan. Hypertens Res. 2010;33:652–6. The Ohasama study was one of the first epidemiological studies that reinforced the role of nocturnal hypertension in target organ damage and cardiovascular prognosis. This article shows the importance of nocturnal hypertension, particularly in stroke.

    Article  PubMed  Google Scholar 

  23. Maa JK, Sun JL, Zhao J, et al. Relationship between nocturnal blood pressure variation and silent cerebral infarction in Chinese hypertensive patients. J Neurol Sci. 2010;294:67–9.

    Article  Google Scholar 

  24. Kario K, Pickering TG, Umeda Y, et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation. 2003;107:1401–6.

    Article  PubMed  Google Scholar 

  25. Gosse P, Lasserre R, Minifié C, et al. Blood pressure surge on rising. J Hypertens. 2004;22:1113–8.

    Article  PubMed  CAS  Google Scholar 

  26. Metoki H, Ohkubo T, Kikuya M, et al. Prognostic significance for stroke of a morning pressor surge and a nocturnal blood pressure decline: the Ohasama Study. Hypertension. 2006;47:149–54.

    Article  PubMed  CAS  Google Scholar 

  27. Ohkubo T, Metoki H, Imai Y. Prognostic significance of morning surge in blood pressure: which definition, which outcome? Blood Press Monit. 2008;13:161–2.

    Article  PubMed  Google Scholar 

  28. Staessen JA, Thijs L, O’Brien ET, et al. Ambulatory pulse pressure as predictor outcome in older patients with systolic hypertension. Am J Hypertens. 2002;15:835–43.

    Article  PubMed  Google Scholar 

  29. • Aznaouridis K, Vlachopoulos C, Protogerou A, et al. Ambulatory systolic–diastolic pressure regression index as a predictor of clinical events: a meta-analysis of longitudinal studies. Stroke. 2012;43:733–9. This is an interesting and recent meta-analysis of new markers of arterial stiffness measured by ambulatory systolic and diastolic values and the relevance of this data as a predictor of cardiovascular events.

    Article  PubMed  Google Scholar 

  30. Emelianov D, Thijs L, Staessen JA, et al. Conventional and ambulatory measurements of blood pressure in old patients with isolated systolic hypertension: baseline observations in the Syst-Eur trial. Blood Press Monit. 1998;3:173–80.

    PubMed  Google Scholar 

  31. Fagard R, Staessen JA, Thijs L, et al. Response to antihypertensive therapy in older patients with sustained and nonsustained systolic hypertension. Circulation. 2000;102:1139–44.

    Article  PubMed  CAS  Google Scholar 

  32. Bulpitt CJ, Beckett N, Peters R, et al. Does white coat hypertension require treatment over age 80? Results of the Hypertension in the Very Elderly Trial Ambulatory Blood Pressure Side Project. Hypertension. 2013;61:89–94.

    Article  PubMed  CAS  Google Scholar 

  33. Vemmos KN, Tsivgoulis G, Spengos K, Zakopoulos N, Synetos A, Kotsis V, et al. Association between 24-h blood pressure monitoring variables and brain oedema in patients with hyperacute stroke. J Hypertens. 2003;21:2167–73.

    Article  PubMed  CAS  Google Scholar 

  34. • Tomii Y, Toyoda K, Suzuki R, Naganuma M, Fujinami J, Yokota CH, et al. Effects of 24-hour blood pressure and heart rate recorded with ambulatory blood pressure monitoring on recovery from acute ischemic stroke. Stroke. 2011;42:3511–7. This article shows the correlation between high BP values by ABPM at the acute phase of stroke and outcomes, demonstrating that high BP values are correlated to worse outcomes.

    Article  PubMed  Google Scholar 

  35. Yamamoto Y, Akiguchi I, Oiwa K, Hayashi M, Kimura J. Adverse effect of nighttime blood pressure on the outcome of lacunar infarct patients. Stroke. 1998;29:570–6.

    Article  PubMed  CAS  Google Scholar 

  36. Yamamoto Y, Akiguchi I, Oiwa K, Hayashi M, Kasai T, Ozasa K. Twenty-four-hour blood pressure and MRI as predictive factors for different outcomes in patients with lacunar infarct. Stroke. 2002;33:297–305.

    PubMed  CAS  Google Scholar 

  37. Chamorro A, Pujol J, Saiz A, Vila N, Vilanova JC, Alday M, et al. Periventricular white matter lucencies in patients with lacunar stroke. A marker of too high or too low blood pressure. Arch Neurol. 1997;54:1284–8.

    Article  PubMed  CAS  Google Scholar 

  38. • Zakopoulos N, Spengos K, Tsivgoulis G, Zis V, Manios E, Vemmos K. Assessment of blood pressure control in hypertensive stroke survivors: an ambulatory blood pressure monitoring study. Blood Press Monit. 2006;11:235–41. In this article the authors tried to find how frequent masked hypertension is present in stroke and which are the determinants of this clinical situation.

    Article  PubMed  Google Scholar 

  39. Nakamura K, Oita J, Yamaguchi T. Nocturnal blood pressure dip in stroke survivors: a pilot study. Stroke. 1995;26:1373–8.

    Article  PubMed  CAS  Google Scholar 

  40. Castilla-Guerra L, Fernández-Moreno MC, Espino-Montoro A, López-Chozas JM. Ambulatory blood pressure monitoring in stroke survivors: do we really control our patients? Eur J Int Med. 2009;20:760–3.

    Article  Google Scholar 

  41. Phillips RA, Sheinart KF, Godbold JA, Mahboob R, Tuhrim S. The association of blunted nocturnal blood pressure dip and stroke in a multiethnic population. Am J Hypertens. 2000;13:1250–5.

    Article  PubMed  CAS  Google Scholar 

  42. Phillips RA, Butkevich A, Sheinart KF, Tuhrim S. Dipping is superior to cusums analysis in assessment of the risk of stroke in a case–control study. Am J Hypertens. 2001;14:649–52.

    Article  PubMed  CAS  Google Scholar 

  43. Schrader J, Lüders S, Kulschewski A, Hammersen F, Plate K, Berger J, et al. Morbidity and mortality after stroke, eprosartan compared with nitrendipine for secondary prevention principal results of a prospective randomized controlled study (MOSES). Stroke. 2005;36:1218–26.

    Article  PubMed  CAS  Google Scholar 

  44. • Sierra C, Doménech M, Camafort M, Coca A. Hypertension and mild cognitive impairment. Curr Hypertens Rep. 2012;14:548–55. Recent review about the role of high blood pressure in developing cognitive impairment.

    Article  PubMed  CAS  Google Scholar 

  45. Novak V, Hajjar I. The relationship between blood pressure and cognitive function. Nat Rev Cardiol. 2010;7:686–98.

    PubMed  Google Scholar 

  46. • Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 2010;9:689–701. Most complete review about cerebral WML with relation to pathogenesis and clinical characteristics.

    Article  PubMed  Google Scholar 

  47. • Gorelick PB, Scuteri A, Black SE, et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42:2672–713. A review summarizing the evidence about the association between vascular risk factors and cognitive impairment/dementia.

    Article  PubMed  Google Scholar 

  48. Van Boxtel MP, Henskens LH, Kroon AA, et al. Ambulatory blood pressure, asymptomatic cerebrovascular damage and cognitive function in essential hypertension. J Hum Hypertens. 2006;20:5–13.

    Article  PubMed  Google Scholar 

  49. Kanemaru A, Kanemaru K, Kuwajima I. The effects of short-term blood pressure variability and nighttime blood pressure levels on cognitive function. Hypertens Res. 2001;24:19–24.

    Article  PubMed  CAS  Google Scholar 

  50. Bellelli G, Frisoni GB, Lucchi E, et al. Blunted reduction in night-time blood pressure is associated with cognitive deterioration in subjects with long-standing hypertension. Blood Press Monit. 2004;9:71–6.

    Article  PubMed  Google Scholar 

  51. Sakakura K, Ishikawa J, Okuno M, et al. Exaggerated ambulatory blood pressure variability is associated with cognitive dysfunction in the very elderly and quality of life in the younger elderly. Am J Hypertens. 2007;20:720–7.

    Article  PubMed  Google Scholar 

  52. Axelsson J, Reinprecht F, Siennicki-Lantz A, Elmståhl S. Low ambulatory blood pressure is associated with lower cognitive function in healthy elderly men. Blood Press Monit. 2008;13:269–75.

    Article  PubMed  Google Scholar 

  53. • Birns J, Morris R, Jarosz J, Markus H, Kalra L. The structural and functional consequences of diurnal variations in blood pressure in treated patients with hypertensive cerebrovascular disease. J Hypertens. 2009;27:1042–8. One of the first studies showing that treated hypertensive patients with excessive nocturnal BP fall and silent cerebrovascular disease have greater structural and functional lesions.

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of Interest

A. Coca has received payment for serving as a consultant from Menarini, Chiesi, Novartis, Sanofi, Ferrer, and Medtronic; has received payment for lectures including service on speakers bureaus from Menarini, Chiesi, Esteve, Novartis, Sanofi, Ferrer, Daiichi-Sankyo, and Servier; and payment for the development of educational presentations from Menarini and Ferrer.

M. Camafort has received payment for lectures including service on speakers bureaus from Daiichi-Sankyo, Menarini, Chiesi, Esteve, Novartis, and Ferrer.

M. Doménech has received payment for lectures including service on speakers bureaus from Astra-Zeneca, Daiichi-Sankyo, Chiesi, Esteve, Ferrer and Menarini.

C. Sierra has received payment for lectures including service on speakers bureaus from Daiichi-Sankyo, Chiesi, Esteve, and Ferrer.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Antonio Coca.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Coca, A., Camafort, M., Doménech, M. et al. Ambulatory Blood Pressure in Stroke and Cognitive Dysfunction. Curr Hypertens Rep 15, 150–159 (2013). https://doi.org/10.1007/s11906-013-0346-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11906-013-0346-3

Keywords

Navigation